Abbonarsi

Machine Learning Identifies Clinically Distinct Phenotypes in Patients With Aortic Regurgitation - 02/04/25

Doi : 10.1016/j.echo.2024.10.019 
Brototo Deb, MD, MIDS a, b, Christopher G. Scott, MS c, Hector I. Michelena, MD, PhD b, Sorin V. Pislaru, MD, PhD b, Vuyisile T. Nkomo, MD, MPH b, Garvan C. Kane, MD, PhD b, Juan A. Crestanello, MD d, Patricia A. Pellikka, MD b, Vidhu Anand, MD b, e,
a Department of Medicine, Georgetown University, Washington, District of Columbia 
b Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota 
c Department of Biostatistics, Mayo Clinic, Rochester, Minnesota 
d Department of Cardiothoracic Surgery, Mayo Clinic, Rochester, Minnesota 
e Department of Cardiovascular Medicine, Mayo Clinic Health System, Eau Claire, Wisconsin 

Reprint requests: Vidhu Anand, MBBS, Mayo Clinic College of Medicine and Science, Department of Cardiovascular Medicine, 200 First Street SW, Rochester, MN.Mayo Clinic College of Medicine and ScienceDepartment of Cardiovascular Medicine200 First Street SWRochesterMN

Abstract

Background

Aortic regurgitation (AR) is a prevalent valve disease with a long latent period before symptoms appear. Recent data has suggested the role of novel markers of myocardial overload in assessing onset of decompensation.

Methods

The aim of this study was to evaluate the role of unsupervised cluster analyses in identifying different clinical clusters, including clinical status, and a large number of echocardiographic variables including left ventricular volumes, and their associations with mortality. Patients with moderate to severe or greater chronic AR identified using echocardiography at the Mayo Clinic in Rochester, Minnesota, were retrospectively analyzed. The primary outcome was all-cause mortality censored at aortic valve surgery. Uniform manifold approximation and projection with the k-means algorithm was used to cluster patients using clinical and echocardiographic variables at the time of presentation. Missing data were imputed using the multiple imputation by chained equations method. A supervised approach trained on the training set was used to find cluster membership in a hold-out validation set. Log-rank tests were used to assess differences in mortality rates among the clusters in both the training and validation sets.

Results

Three distinct clusters were identified among 1,100 patients (log-rank P for survival < .001). Cluster 1 (n = 337), which included younger males with severe AR but fewer symptoms, showed the best survival at 75.6% (95% CI, 69.5%-82.3%). Cluster 2 (n = 235), including older patients and more females with elevated filling pressures, showed intermediate survival of 64.2% (95% CI, 56.8%-72.5%). Cluster 3 (n = 253), characterized by severe symptomatic AR, demonstrated the lowest survival of 45.3% (95% CI, 34.4%-59.8%) at 5 years. Similar clusters were identified in the internal validation cohort.

Conclusions

Distinct clusters with variable echocardiographic features and mortality differences exist within patients with chronic moderate to severe or greater AR. Recognizing these clusters can refine individual risk stratification and clinical decision-making after verification in future prospective studies.

Il testo completo di questo articolo è disponibile in PDF.

Central Illustration

One thousand one hundred patients were divided into development (n = 825) and validation (n = 275) cohorts. In the development cohort, symptoms, echocardiographic features, and blood pressure were used to phenotype patients into three clusters with unique characteristics and differential all-cause mortality. Cluster 1 included mostly severe but relatively asymptomatic men. Cluster 2 was characterized by older women with the least severe AR and higher filling pressures, and cluster 3 included primarily men with the highest severity (largest EROAs and regurgitant volumes), the highest proportion with reduced EFs, larger LV size, and symptomatic AR.



Central Illustration : 

One thousand one hundred patients were divided into development (n = 825) and validation (n = 275) cohorts. In the development cohort, symptoms, echocardiographic features, and blood pressure were used to phenotype patients into three clusters with unique characteristics and differential all-cause mortality. Cluster 1 included mostly severe but relatively asymptomatic men. Cluster 2 was characterized by older women with the least severe AR and higher filling pressures, and cluster 3 included primarily men with the highest severity (largest EROAs and regurgitant volumes), the highest proportion with reduced EFs, larger LV size, and symptomatic AR. [To note - the cluster and survival analysis data is for representation only. Refer to Figure 1 for study-specific data. Figure created with BioRender].


Central IllustrationOne thousand one hundred patients were divided into development (n = 825) and validation (n = 275) cohorts. In the development cohort, symptoms, echocardiographic features, and blood pressure were used to phenotype patients into three clusters with unique characteristics and differential all-cause mortality. Cluster 1 included mostly severe but relatively asymptomatic men. Cluster 2 was characterized by older women with the least severe AR and higher filling pressures, and cluster 3 included primarily men with the highest severity (largest EROAs and regurgitant volumes), the highest proportion with reduced EFs, larger LV size, and symptomatic AR. [To note - the cluster and survival analysis data is for representation only. Refer to Figure 1 for study-specific data. Figure created with BioRender].

Il testo completo di questo articolo è disponibile in PDF.

Highlights

In severe AR, ML identified clusters using clinical and echocardiographic features.
Three clusters differed in demographics, LV remodeling, AR severity, and symptoms.
Mortality increased from cluster 1 to cluster 3.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Aortic regurgitation, Machine learning, Cluster analyses, Echocardiography

Abbreviations : AR, EF, EROA, LV, ML, NYHA, RVSP, UMAP


Mappa


 This work was funded by an intramural grant from the Department of Cardiovascular Ultrasound, Mayo Clinic.
 Raymond Stainback, MD, served as guest editor for this report.


© 2024  American Society of Echocardiography. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 38 - N° 4

P. 300-309 - aprile 2025 Ritorno al numero
Articolo precedente Articolo precedente
  • Thank You, JASE Reviewer Team!
  • Patricia A. Pellikka
| Articolo seguente Articolo seguente
  • Reevaluating Normal-Flow Low-Gradient Severe Aortic Stenosis: Clinical Phenotypes and Outcomes in Severe Aortic Stenosis Among Transcatheter Aortic Valve Replacement Patients
  • Amro Badr, Mustafa Suppah, Kamal Awad, Juan Farina, Bobbi Jo Heon, Rachel Wraith, Bishoy Abraham, Sara Kaldas, Vuyisile Nkomo, Reza Arsanjani, Chieh-Ju Chao, David Holmes, Said Alsidawi

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.